For: | Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, Yang DL, Hao LJ. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6(6): 805-811 [PMID: 11819700 DOI: 10.3748/wjg.v6.i6.805] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/805.htm |
Number | Citing Articles |
1 |
Kenneth E. Sherman, Norah J. Shire, Susan D. Rouster, Marion G. Peters, Margaret James Koziel, Raymond T. Chung, Paul S. Horn. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology 2005; 128(2): 313 doi: 10.1053/j.gastro.2004.11.059
|
2 |
Helal F. Hetta, Mohamed A. Mekky, Nasr K. Khalil, Wegdan A. Mohamed, Mohamed A. El-Feky, Shabaan H. Ahmed, Enas A. Daef, Ahmed Medhat, Mahmoud I. Nassar, Kenneth E. Sherman, Mohamed Tarek M. Shata. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. Journal of Medical Microbiology 2016; 65(8): 703 doi: 10.1099/jmm.0.000272
|
3 |
María Laura Polo, Natalia Laufer. Extrahepatic manifestations of HCV: the role of direct acting antivirals. Expert Review of Anti-infective Therapy 2017; 15(8): 737 doi: 10.1080/14787210.2017.1354697
|
4 |
Nikola Panic, Sladjana Mihajlovic, Miroslav Vujasinovic, Milutin Bulajic, Johannes-Matthias Löhr. Pancreatitis Associated with Viral Hepatitis: Systematic Review. Journal of Clinical Medicine 2020; 9(10): 3309 doi: 10.3390/jcm9103309
|
5 |
Juan F. Gallegos-Orozco, Jorge Rakela, Marianne J. Rosati, Hugo E. Vargas, Vijayan Balan. Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy. Digestive Diseases and Sciences 2008; 53(9): 2564 doi: 10.1007/s10620-008-0323-x
|
6 |
Yan-Wei Zhong, Jun Cheng, Gang Wang, Shuang-Shuang Shi, Li Li, Ling-Xia Zhang, Ju-Mei Chen. Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry. World Journal of Gastroenterology 2002; 8(5): 863-867 doi: 10.3748/wjg.v8.i5.863
|
7 |
Xu Li, Pujun Gao. Hepatitis C Virus Infection Increases Risk of Gallstone Disease in Elderly Chinese Patients with Chronic Liver Disease. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22896-4
|
8 |
Mario Masarone, Marcello Persico. Hepatitis C virus infection and non‐hepatocellular malignancies in the DAA era: A systematic review and meta‐analysis. Liver International 2019; 39(7): 1292 doi: 10.1111/liv.14119
|
9 |
NASIR KHOKHAR. Late relapse in chronic hepatitis c after sustained viral response to interferon and ribavirin. Journal of Gastroenterology and Hepatology 2004; 19(4): 471 doi: 10.1111/j.1440-1746.2004.03289.x
|
10 |
Minoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, Shuji Sumie, Tetsuharu Oriishi, Keiichi Mitsuyama, Osamu Tsuruta, Takato Ueno, Michio Sata. Altered expression of glucagon‐like peptide‐1 and dipeptidyl peptidase IV in patients with HCV‐related glucose intolerance. Journal of Gastroenterology and Hepatology 2008; 23(2): 244 doi: 10.1111/j.1440-1746.2007.05183.x
|
11 |
Xu Li, Zhongfeng Wang, Le Wang, Meng Pan, Pujun Gao. Liver cirrhosis. Medicine 2017; 96(26): e7427 doi: 10.1097/MD.0000000000007427
|
12 |
Giovanna Russelli, Paola Pizzillo, Gioacchin Iannolo, Floriana Barbera, Fabio Tuzzolino, Rosa Liotta, Mario Traina, Giovanni Vizzini, Bruno Gridelli, Ester Badami, Pier Giulio Conaldi, Birke Bartosch. HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation. PLOS ONE 2017; 12(7): e0181683 doi: 10.1371/journal.pone.0181683
|
13 |
Rong-Qin Zheng, Qing-Hui Wang, Ming-De Lu, Shi-Bin Xie, Jie Ren, Zhong-Zhen Su, Yin-Ke Cai, Ji-Lu Yao. Liver fibrosis in chronic viral hepatitis: An ultrasonographic study. World Journal of Gastroenterology 2003; 9(11): 2484-2489 doi: 10.3748/wjg.v9.i11.2484
|
14 |
Vicente Carreño, Javier Bartolomé, Inmaculada Castillo. Congenital and Other Related Infectious Diseases of the Newborn. Perspectives in Medical Virology 2006; 13: 109 doi: 10.1016/S0168-7069(06)13007-4
|
15 |
S. Fiorino, S. Lorenzini, M. Masetti, G. Deleonardi, A.G. Grondona, T. Silvestri, E. Chili, P. Del Prete, L. Bacchi-Reggiani, A. Cuppini, E. Jovine. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Medical Hypotheses 2012; 79(5): 678 doi: 10.1016/j.mehy.2012.08.008
|
16 |
Maryann Mugo, Ravina Matta, L Romayne Kurukulasuriya, James R. Sowers. Association of Hepatitis C Virus Infection and Diabetes Mellitus. The Endocrinologist 2006; 16(1): 41 doi: 10.1097/01.ten.0000194250.94931.d0
|
17 |
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi. Sars-CoV-2: Lessons from Both the History of Medicine and from the Biological Behavior of Other Well-Known Viruses. Future Microbiology 2021; 16(14): 1105 doi: 10.2217/fmb-2021-0064
|
18 |
Elizabeth File, Mandeep Mehra, Satheesh Nair, Debbie Dumas-Hicks, Robert Perrillo. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation 2003; 76(7): 1096 doi: 10.1097/01.TP.0000088663.76640.C9
|
19 |
Jason T. Blackard, Ling Kong, Angela Lombardi, Dirk Homann, Sara Salehi Hammerstad, Yaron Tomer. A preliminary analysis of hepatitis C virus in pancreatic islet cells. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0905-3
|
20 |
Aiat Shaban Hemida, Mohamed Mohamady Ahmed, Mona Saeed Tantawy. HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression. Diagnostic Pathology 2024; 19(1) doi: 10.1186/s13000-024-01563-5
|
21 |
G. Tarantino, P. Conca, M. Ariello, A. Arena. Exaggerated Immune Reactions Predict the Outcome of Interferon Therapy in Patients with Chronic Hepatitis C. International Journal of Immunopathology and Pharmacology 2007; 20(4): 837 doi: 10.1177/039463200702000421
|
22 |
N. V. Dunaeva, M. Yu. Pervakova, A. S. Mazing, S. V. Lapin. Incidence and risk factors of extrahepatic manifestations in patients with chronic HCV and HCV/HIV infection. HIV Infection and Immunosuppressive Disorders 2022; 13(4): 53 doi: 10.22328/2077-9828-2021-13-4-53-63
|
23 |
Sirio Fiorino. HBV and HCV infection and pancreatic ductal adenocarcinoma. Hepatobiliary & Pancreatic Diseases International 2013; 12(6): 570 doi: 10.1016/S1499-3872(13)60090-9
|
24 |
Bo Liu, Yongxiang Zhang, Jun Li, Weihong Zhang. Hepatitis C virus and risk of extrahepatic malignancies: a case-control study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55249-w
|
25 |
Paolo Caliceti. Pharmacokinetics of pegylated interferons: What is misleading?. Digestive and Liver Disease 2004; 36: S334 doi: 10.1016/S1590-8658(04)80002-1
|
26 |
Jian Wang, Gui-Ju Xiang, Bing-Xiang Liu. Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C. World Journal of Gastroenterology 2003; 9(4): 751-754 doi: 10.3748/wjg.v9.i4.751
|
27 |
Javier Bartolomé, Elena Rodríguez‐Iñigo, Pedro Quadros, Sonia Vidal, Isabel Pascual‐Miguelañez, José Antonio Rodríguez‐Montes, Luis García‐Sancho, Vicente Carreño. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. Journal of Medical Virology 2008; 80(9): 1588 doi: 10.1002/jmv.21269
|
28 |
Charles Nordin, Amit Kohli, Sorin Beca, Valentin Zaharia, Taneisha Grant, Jason Leider, Paul Marantz. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. Journal of Electrocardiology 2006; 39(2): 199 doi: 10.1016/j.jelectrocard.2005.09.001
|
29 |
Parag Mahale, Harrys A. Torres, Jennifer R. Kramer, Lu‐Yu Hwang, Ruosha Li, Eric L. Brown, Eric A. Engels. Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry‐based case‐control study. Cancer 2017; 123(7): 1202 doi: 10.1002/cncr.30559
|
30 |
Edmund J. Bini, John McGready. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States†. Hepatology 2005; 41(5): 1029 doi: 10.1002/hep.20647
|
31 |
Patricia Pérez-Matute, María Íñiguez, María J. Villanueva-Millán, Emma Recio-Fernández, Aitana Morano Vázquez, Sheila Castro Sánchez, Luís E. Morano, José A. Oteo. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients. European Journal of Internal Medicine 2019; 67: 47 doi: 10.1016/j.ejim.2019.06.005
|
32 |
Rosana Gelpi, Camino Rodríguez-Villar, David Paredes, Rebeca Roque, Angel Ruiz, Ramon Adalia, Erika de Sousa, Ignacio Revuelta, Manuel Sole, Miguel Martinez, Mireia Navarro, Sabela Lens, Federico Oppenheimer, Fritz Diekmann. Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies. Transplant International 2018; 31(8): 938 doi: 10.1111/tri.13270
|
33 |
Takumi Kawaguchi, Tatsuya Ide, Eitaro Taniguchi, Eiichi Hirano, Minoru Itou, Shuji Sumie, Yumiko Nagao, Chikatoshi Yanagimoto, Shinichiro Hanada, Hironori Koga, Michio Sata. Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2. The American Journal of Gastroenterology 2007; 102(3): 570 doi: 10.1111/j.1572-0241.2006.01038.x
|
34 |
Mohsen Nakhaie, Javad Charostad, Gholam Abbas Kaydani, Ebrahim Faghihloo. The role of viruses in adenocarcinoma development. Infection, Genetics and Evolution 2020; 86: 104603 doi: 10.1016/j.meegid.2020.104603
|
35 |
Gül Bahtiyar, John J. Shin, Ayse Aytaman, James R. Sowers, Samy I. McFarlane. Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights. Current Diabetes Reports 2004; 4(3): 194 doi: 10.1007/s11892-004-0023-7
|
36 |
Giada Pietrosi, Giovanna Russelli, Floriana Barbera, Gabriele Curcio, Fabio Tuzzolino, Alessia Gallo, Riccardo Volpes, Giovanni Vizzini, Pier Giulio Conaldi. Direct‐acting antivirals ability to clear intestinal HCV‐RNA in liver transplant patients. Transplant Infectious Disease 2020; 22(5) doi: 10.1111/tid.13345
|
37 |
A. Pruss, G. Caspari, D.H. Krüger, J. Blümel, C.M. Nübling, L. Gürtler, W.H. Gerlich. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transplant Infectious Disease 2010; 12(5): 375 doi: 10.1111/j.1399-3062.2010.00505.x
|
38 |
Shih-Chi Wu, Sheng-fung Lin, Chu-Wen Fang, I-Ju Tsai, Wen-Chi Yang. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53165-7
|
39 |
Xi Peng, Jin-Bin Feng, Hong Yan, Yun Zhao, Shi-Liang Wang. Distribution of nitric oxide synthase in stomach myenteric plexus of rats. World Journal of Gastroenterology 2001; 7(6): 852-854 doi: 10.3748/wjg.v7.i6.852
|
40 |
Lucia Miglioresi, Elisabetta Riva, Guido Antonelli, Francesca Russo, Giovanni L. Ricci. Localization of Hepatitis C Virus in Gastrointestinal Mucosa: A Possible Reservoir for Relapse. Hepatology 2003; 38(3): 775 doi: 10.1053/jhep.2003.50322
|
41 |
Philip Hilgard, Alisan Kahraman, Nils Lehmann, Cornelia Seltmann, Susanne Beckebaum, R Stefan Ross, Hideo A Baba, Massimo Malago, Christoph E Broelsch, Guido Gerken. Cyclosporine <italic>versus</italic> tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitis. World Journal of Gastroenterology 2006; 12(5): 697-702 doi: 10.3748/wjg.v12.i5.697
|
42 |
Viviana Falcón, Nelson Acosta-Rivero, Mineko Shibayama, Glay Chinea, Jorge V. Gavilondo, María C. de la Rosa, Ivón Menéndez, Bienvenido Gra, Santiago Dueñas-Carrera, Ariel Viña, Waldo García, Maritza González-Bravo, Jose Luna-Munoz, Magdalena Miranda-Sanchez, Juan Morales-Grillo, Juan Kouri, Victor Tsutsumi. HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients. Biochemical and Biophysical Research Communications 2005; 329(4): 1320 doi: 10.1016/j.bbrc.2005.02.107
|
43 |
Di Wu, Shiping Hu, Guozi Chen, Longjiao Chen, Jian Liu, Wenlin Chen, Youwen Lv, Xiaoni Chen, Shan Lin, Fenfang Wu. Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studies. Journal of Viral Hepatitis 2021; 28(2): 226 doi: 10.1111/jvh.13434
|
44 |
Antonio Franco, Francesc Moreso, Asuncion Sancho, Nuria Esforzado, Javier Paul, Santiago Llorente, Marta Crespo, Luis Guirado, Eduardo Melilli, Francisco Gonzalez Roncero. Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients. Transplantation Proceedings 2021; 53(9): 2655 doi: 10.1016/j.transproceed.2021.09.013
|
45 |
Jin Ye, B. Brett Finlay. Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus. PLoS Pathogens 2007; 3(8): e108 doi: 10.1371/journal.ppat.0030108
|
46 |
Yuichi Honma, Michihiko Shibata, Kahori Morino, Yudai Koya, Tsuguru Hayashi, Noriyoshi Ogino, Masashi Kusanaga, Shinji Oe, Koichiro Miyagawa, Shintaro Abe, Akinari Tabaru, Masaru Harada. Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C. Digestive Diseases and Sciences 2023; 68(2): 685 doi: 10.1007/s10620-022-07686-3
|
47 |
Li-Hua Chen, Xue-Song Liu, Wen-Yong Wang, Wei-Ning Han, Bo-Rong Pan, Bo-Quan Jin. Localization of TRAIL/TRAILR in fetal pancreas. World Journal of Gastroenterology 2003; 9(2): 334-337 doi: 10.3748/wjg.v9.i2.334
|
48 |
M. Li-Ng, S. Tropp, A. Danoff, E.J. Bini. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Digestive and Liver Disease 2007; 39(6): 549 doi: 10.1016/j.dld.2007.02.014
|
49 |
Shounak Majumder, Bruno Bockorny, William L. Baker, Constantin A. Dasanu. Association Between HBsAg Positivity and Pancreatic Cancer: a Meta-Analysis. Journal of Gastrointestinal Cancer 2014; 45(3): 347 doi: 10.1007/s12029-014-9618-7
|
50 |
E. V. Esaulenko, K. E. Novak, V. V. Basina, A. A. Dzemova, R. A. Ganchenko. Prevalence of comorbidity in chronic HCV‑infection. Medical alphabet 2021; (1): 66 doi: 10.33667/2078-5631-2021-1-66-70
|
51 |
Albert Lecube, Cristina Hernández, Joan Genescà, Rafael Simó. Glucose Abnormalities in Patients with Hepatitis C Virus Infection. Diabetes Care 2006; 29(5): 1140 doi: 10.2337/dc05-1995
|
52 |
Gina Gheorghe, Camelia Cristina Diaconu, Vlad Ionescu, Gabriel Constantinescu, Nicolae Bacalbasa, Simona Bungau, Mihnea-Alexandru Gaman, Madalina Stan-Ilie. Risk Factors for Pancreatic Cancer: Emerging Role of Viral Hepatitis. Journal of Personalized Medicine 2022; 12(1): 83 doi: 10.3390/jpm12010083
|
53 |
Priya Devi, Seisuke Ota, Tanel Punga, Anders Bergqvist. Hepatitis C Virus Core Protein Down-Regulates Expression of Src-Homology 2 Domain Containing Protein Tyrosine Phosphatase by Modulating Promoter DNA Methylation. Viruses 2021; 13(12): 2514 doi: 10.3390/v13122514
|
54 |
Keisuke Kawai, Katsuya Hata, Hiroya Kawai, Hideyuki Takaoka, Yoko Miyata-Fukuoka, Hideaki Okubo, Mitsuhiro Yokoyama. Pathophysiological Characteristics and Responsiveness to Neurohormonal Antagonism in Idiopathic Dilated Cardiomyopathy Patients With Antihepatitis C Virus Antibody. International Heart Journal 2005; 46(3): 407 doi: 10.1536/ihj.46.407
|
55 |
Iman Gouda, Ola Nada, Sameera Ezzat, Mai Eldaly, Christopher Loffredo, Clive Taylor, Mohamed Abdel-Hamid. Immunohistochemical Detection of Hepatitis C Virus (Genotype 4) in B-cell NHL in an Egyptian Population. Applied Immunohistochemistry & Molecular Morphology 2010; 18(1): 29 doi: 10.1097/PAI.0b013e3181ae9e82
|
56 |
Xu Li, Xiaolin Guo, Huifan Ji, Ge Yu, Pujun Gao. Gallstones in Patients with Chronic Liver Diseases. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/9749802
|
57 |
Mariya A. Derbak, Olha V. Buchok, Taras M. Ganich, Mariya V. Rivis, Yana V. Lazur, Viktoriya M. Polyak-Tovt, Volodymyr V. Timashev. PECULIARITIES OF THE FUNCTIONAL STATE OF THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS C IN THE PRESENCE OF CHRONIC PANCREATITIS. Wiadomości Lekarskie 2023; 76(11): 2359 doi: 10.36740/WLek202311103
|
58 |
Tarek Saadi, Johad Khoury. Is There a Relationship Between Treatment With Direct Antiviral Agents for HCV Infection and the Development of Malignancies?. Journal of Clinical Gastroenterology 2018; 52(4): 353 doi: 10.1097/MCG.0000000000000853
|
59 |
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
|
60 |
Shuai Xing, Zhi-Wei Li, Yuan-Feng Tian, Li-Min Zhang, Ming-Qiang Li, Ping Zhou. Chronic heaatitis virus infection increases the risk of aancreatic cancer: a meta-analysis. Hepatobiliary & Pancreatic Diseases International 2013; 12(6): 575 doi: 10.1016/S1499-3872(13)60091-0
|
61 |
Xiao-Fang Liu, Sheng-Quan Zou, Fa-Zu Qiu. Construction of HCV-core gene vector and its expression in cholangiocarcinoma. World Journal of Gastroenterology 2002; 8(1): 135-138 doi: 10.3748/wjg.v8.i1.135
|
62 |
Jie Yan, Li-Li Chen, Yong-Liang Lou, Xiao-Zhi Zhong. Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases. World Journal of Gastroenterology 2002; 8(5): 857-862 doi: 10.3748/wjg.v8.i5.857
|
63 |
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed A. Abdelrazek, Mohamed M. Omran, Ashraf Z. Mahmoud, Hager S. Khalifa, Mohamed M. Ahmed, Ibrahim El-Dosoky. HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer. Breast Cancer 2018; 25(3): 297 doi: 10.1007/s12282-017-0829-1
|
64 |
D. Shichi, E.F. Kikkawa, M. Ota, Y. Katsuyama, A. Kimura, A. Matsumori, J.K. Kulski, T.K. Naruse, H. Inoko. The haplotype block, NFKBIL1‐ATP6V1G2‐BAT1‐MICB‐MICA, within the class III – class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus‐associated dilated cardiomyopathy. Tissue Antigens 2005; 66(3): 200 doi: 10.1111/j.1399-0039.2005.00457.x
|
65 |
Antonio Franco, Carla Gosalvez, Adelina Gimeno, Migul Trigueros, Noelia Balibrea, Francisco Javier Perez Contreras. Assessing Tissue Transmission of Hepatitis C Virus From Viremic Donor to Seronegative Kidney Transplant Recipients: A Case Series. Transplant International 2023; 36 doi: 10.3389/ti.2023.11110
|
66 |
Javier Bartolomé, Elena Rodríguez‐Iñigo, Alejo Erice, Sonia Vidal, Inmaculada Castillo, Vicente Carreño. Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C. Journal of Medical Virology 2007; 79(12): 1818 doi: 10.1002/jmv.21005
|
67 |
Hajime Masuda, Toshiya Atsumi, Atsushi Fujisaku, Chikara Shimizu, Narihito Yoshioka, Takao Koike. Acute onset of type 1 diabetes accompanied by acute hepatitis C: The potential role of proinflammatory cytokine in the pathogenesis of autoimmune diabetes. Diabetes Research and Clinical Practice 2007; 75(3): 357 doi: 10.1016/j.diabres.2006.07.016
|
68 |
Chun-Wei Chen, Jur- Shan Cheng, Tsung-Hsing Chen, Chia-Jung Kuo, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Different Metabolic Associations of Hepatitis C With Colon and Rectal Cancers: A 9-Year Nationwide Population-Based Cohort Study. Clinical Colorectal Cancer 2024; doi: 10.1016/j.clcc.2024.08.005
|
69 |
Séverine Deforges, Alexey Evlashev, Magali Perret, Mireille Sodoyer, Stéphane Pouzol, Jean-Yves Scoazec, Bertrand Bonnaud, Olivier Diaz, Glaucia Paranhos-Baccalà, Vincent Lotteau, Patrice André. Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo. Journal of General Virology 2004; 85(9): 2515 doi: 10.1099/vir.0.80071-0
|
70 |
N. Goldaracena, V.N. Spetzler, J. Echeverri, J.M. Kaths, V. Cherepanov, R. Persson, M.R. Hodges, H.L.A. Janssen, N. Selzner, D.R. Grant, J.J. Feld, M. Selzner. Inducing Hepatitis C Virus Resistance After Pig Liver Transplantation—A Proof of Concept of Liver Graft Modification Using Warm Ex Vivo Perfusion. American Journal of Transplantation 2017; 17(4): 970 doi: 10.1111/ajt.14100
|
71 |
Clodoveo Ferri, Jordan J Feld, Mark Bondin, Patrice Cacoub. Expert Opinion on Managing Chronic HCV in Patients with Non-Hodgkin Lymphoma and other Extrahepatic Malignancies. Antiviral Therapy 2018; 23(1_suppl): 23 doi: 10.3851/IMP3250
|
72 |
Chuanfang Luo, Shuhui Yu, Jinping Zhang, Xingrao Wu, Zhongyan Dou, Zheng Li, E. Yang, Lan Zhang. Hepatitis B or C viral infection and the risk of cervical cancer. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00466-8
|
73 |
Aviyah Peri, Nadja Salomon, Yochai Wolf, Sebastian Kreiter, Mustafa Diken, Yardena Samuels. The landscape of T cell antigens for cancer immunotherapy. Nature Cancer 2023; 4(7): 937 doi: 10.1038/s43018-023-00588-x
|
74 |
Daniele Borsetto, Jonathan Fussey, Luca Fabris, Luigia Bandolin, Piergiorgio Gaudioso, Veronica Phillips, Jerry Polesel, Paolo Boscolo-Rizzo. HCV infection and the risk of head and neck cancer: A meta-analysis. Oral Oncology 2020; 109: 104869 doi: 10.1016/j.oraloncology.2020.104869
|
75 |
RNA interference: The story of gene silencing in plants and humans. Biotechnology Advances 2008; 26(3): 202 doi: 10.1016/j.biotechadv.2007.12.002
|
76 |
Maya Balakrishnan, Matthew T. Glover, Fasiha Kanwal. Hepatitis C and Risk of Nonhepatic Malignancies. Clinics in Liver Disease 2017; 21(3): 543 doi: 10.1016/j.cld.2017.03.009
|
77 |
|
78 |
Quan-Chu Wang, Qing-He Nie, Zhi-Hua Feng. RNA interference: Antiviral weapon and beyond. World Journal of Gastroenterology 2003; 9(8): 1657-1661 doi: 10.3748/wjg.v9.i8.1657
|
79 |
Daniel Segna, Jean-François Dufour. Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clinics in Liver Disease 2017; 21(3): 607 doi: 10.1016/j.cld.2017.03.014
|
80 |
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana. Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI. Revista Colombiana de Gastroenterología 2019; 34(3): 277 doi: 10.22516/25007440.322
|
81 |
Ke Li, Lin Wang, Jun Cheng, Yin-Ying Lu, Ling-Xin Zhang, Jin-Song Mu, Yuan Hong, Yan Liu, Hui-Juan Duan, Gang Wang, Li Li, Ju-Mei Chen. Interaction between hepatitis C virus core protein and translin protein- a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus. World Journal of Gastroenterology 2003; 9(2): 300-303 doi: 10.3748/wjg.v9.i2.300
|
82 |
旭君 王. Analysis of Risk Factors of Gallbladder Stones in the Elderly. Advances in Clinical Medicine 2021; 11(09): 3912 doi: 10.12677/ACM.2021.119572
|
83 |
Fu-Hsiung Su, Chyi-Huey Bai, Thi Nga Le, Chih-Hsin Muo, Shih-Ni Chang, Arlene Te, Fung-Chang Sung, Chih-Ching Yeh. Patients With Chronic Hepatitis C Virus Infection Are at an Increased Risk of Colorectal Cancer: A Nationwide Population-Based Case-Control Study in Taiwan. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.561420
|
84 |
Hong-Chao Zhou, De-Zhong Xu, Xue-Ping Wang, Jing-Xia Zhang, Ying-Huang, Yong-Ping Yan, Yong Zhu, Bo-Quan Jin. Identification of the epitopes on HCV core protein recognized by HLA-A<italic>2</italic> restricted cytotoxic T lymphocytes. World Journal of Gastroenterology 2001; 7(4): 583-586 doi: 10.3748/wjg.v7.i4.583
|
85 |
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infection. Nature Reviews Gastroenterology & Hepatology 2018; 15(5): 283 doi: 10.1038/nrgastro.2017.172
|
86 |
Hubert Darius J. Daniel, Joel David, Paul R. Grant, Jeremy A. Garson, George M. Chandy, Priya Abraham. Whole Blood as an Alternative to Plasma for Detection of Hepatitis C Virus RNA. Journal of Clinical Microbiology 2008; 46(11): 3791 doi: 10.1128/JCM.00045-08
|
87 |
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
|
88 |
Natalia Michalak, Ewa Małecka-Wojciesko. Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors. Journal of Clinical Medicine 2023; 12(13): 4318 doi: 10.3390/jcm12134318
|